ZA874482B - Method of chain combination - Google Patents

Method of chain combination

Info

Publication number
ZA874482B
ZA874482B ZA874482A ZA874482A ZA874482B ZA 874482 B ZA874482 B ZA 874482B ZA 874482 A ZA874482 A ZA 874482A ZA 874482 A ZA874482 A ZA 874482A ZA 874482 B ZA874482 B ZA 874482B
Authority
ZA
South Africa
Prior art keywords
chain combination
chain
combination
Prior art date
Application number
ZA874482A
Other languages
English (en)
Inventor
John Perry Burnier
Perry Burnier John
Paul Douglas Johnston
Douglas Johnston Paul
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA874482B publication Critical patent/ZA874482B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA874482A 1986-06-23 1987-06-22 Method of chain combination ZA874482B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/877,819 US4835251A (en) 1986-06-23 1986-06-23 Method of chain combination

Publications (1)

Publication Number Publication Date
ZA874482B true ZA874482B (en) 1989-02-22

Family

ID=25370787

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA874482A ZA874482B (en) 1986-06-23 1987-06-22 Method of chain combination

Country Status (15)

Country Link
US (1) US4835251A (zh)
EP (1) EP0251615B1 (zh)
JP (1) JP2529693B2 (zh)
KR (1) KR960007604B1 (zh)
CN (1) CN1029784C (zh)
AU (1) AU617291B2 (zh)
CA (1) CA1336223C (zh)
DE (1) DE3783273T2 (zh)
DK (1) DK173649B1 (zh)
HU (1) HU205948B (zh)
IE (1) IE59683B1 (zh)
IL (1) IL82921A (zh)
PH (1) PH23407A (zh)
PT (1) PT85134B (zh)
ZA (1) ZA874482B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191063A (en) * 1989-05-02 1993-03-02 University Of Medicine And Dentistry Of New Jersey Production of biologically active polypeptides by treatment with an exogenous peptide sequence
AU623518B2 (en) * 1989-05-04 1992-05-14 Genentech Inc. Processes and compositions for the isolation of human relaxin
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy
US5478807A (en) * 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia
US5911997A (en) * 1995-06-07 1999-06-15 Connetics Corporation Relaxin-like factor and methods and uses thereof
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
US6709659B1 (en) * 1996-08-02 2004-03-23 Zymogenetics, Inc. Antibodies that bind testis-specific insulin homolog polypeptides
US5994148A (en) * 1997-06-23 1999-11-30 The Regents Of University Of California Method of predicting and enhancing success of IVF/ET pregnancy
US6251863B1 (en) 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
US20050032683A1 (en) * 2000-10-04 2005-02-10 Amento Edward P. Methods of modulating apoptosis by administration of relaxin agonists or antagonists
US20050186526A1 (en) * 2002-11-01 2005-08-25 Bas Medical, Inc. Methods and systems for enabling and stabilizing tooth movement
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
WO2005115435A2 (en) * 2004-04-30 2005-12-08 Bas Medical, Inc. Methods and compositions for control of fetal growth via modulation of relaxin
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
AU2007236516B2 (en) * 2006-04-11 2013-01-17 Armour Therapeutics, Inc. Modified H2 relaxin for tumor suppression
GR1006759B (el) * 2008-12-22 2010-04-20 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras) Εξελιγμενη χημικη μεθοδος συνθεσης της ανθρωπινης ρηλαξινης
GR1006941B (el) * 2009-06-01 2010-08-27 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Πεπτιδικη συνθεση (peptide synthesis)
GR1007010B (el) * 2009-10-08 2010-10-07 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Ινσουλινοειδη πεπτιδια
SG10201506443TA (en) 2010-08-17 2015-10-29 Ambrx Inc Modified relaxin polypeptides and their uses
US20160152679A1 (en) * 2012-05-24 2016-06-02 Angion Biomedica Corp. Relaxin-like compounds and uses thereof
US9381231B2 (en) 2012-10-09 2016-07-05 University Of Florida Research Foundation, Inc. Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies
JP6289937B2 (ja) * 2014-02-27 2018-03-07 学校法人東海大学 リラキシンの製造方法
EP2946788A1 (en) 2014-05-23 2015-11-25 Immundiagnostik AG Method and composition for treating heart failure with preserved ejection fraction
EP3371221A2 (en) 2015-11-07 2018-09-12 MultiVir Inc. Methods and compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
JP2020510624A (ja) 2016-12-12 2020-04-09 マルチビア インコーポレイテッド がんおよび感染性疾患の治療および予防のための、ウイルス遺伝子治療および免疫チェックポイント阻害剤を含む方法および組成物
WO2020036635A2 (en) 2018-03-19 2020-02-20 Multivir Inc. Methods and compositions comprising tumor suppressor gene therapy and cd122/cd132 agonists for the treatment of cancer
CA3145491A1 (en) 2019-07-31 2021-02-04 Stacey Lynn Lee Relaxin analogs and methods of using the same
WO2021113644A1 (en) 2019-12-05 2021-06-10 Multivir Inc. Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
WO2021226439A2 (en) * 2020-05-08 2021-11-11 President And Fellows Of Harvard College Engineered relaxins and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1155109A (en) * 1980-03-27 1983-10-11 Ronald E. Chance Process for producing an insulin
US4421685A (en) * 1980-03-27 1983-12-20 Eli Lilly And Company Process for producing an insulin
US4656249A (en) * 1982-06-10 1987-04-07 Howard Florey Institute Of Experimental Physiology And Medicine Peptides with relaxin activity
AU562962B2 (en) * 1982-08-12 1987-06-25 Howard Florey Institute Of Experimental Physiology And Medicine Molecular cloning and characterisation of the gene sequence coding for human relaxin
ATE78042T1 (de) * 1982-08-12 1992-07-15 Florey Howard Inst Analoge des humanen relaxins.
AU562713B2 (en) * 1982-12-13 1987-06-18 Howard Florey Institute Of Experimental Physiology And Medicine Cloning for human relaxin
IL70414A (en) * 1982-12-13 1991-06-10 Florey Howard Inst Polypeptide having human h2-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors

Also Published As

Publication number Publication date
HU205948B (en) 1992-07-28
DK313087A (da) 1987-12-24
CA1336223C (en) 1995-07-04
IE871655L (en) 1987-12-23
DE3783273T2 (de) 1993-05-27
DE3783273D1 (de) 1993-02-11
PH23407A (en) 1989-07-26
DK173649B1 (da) 2001-05-21
CN87104447A (zh) 1988-02-10
AU7462087A (en) 1987-12-24
PT85134A (en) 1987-07-01
HUT44045A (en) 1988-01-28
IL82921A (en) 1992-01-15
KR960007604B1 (ko) 1996-06-07
AU617291B2 (en) 1991-11-28
PT85134B (pt) 1990-03-30
EP0251615A3 (en) 1989-12-13
JP2529693B2 (ja) 1996-08-28
EP0251615B1 (en) 1992-12-30
DK313087D0 (da) 1987-06-19
CN1029784C (zh) 1995-09-20
US4835251A (en) 1989-05-30
KR880000463A (ko) 1988-03-26
JPS6366198A (ja) 1988-03-24
IE59683B1 (en) 1994-03-23
EP0251615A2 (en) 1988-01-07

Similar Documents

Publication Publication Date Title
ZA874482B (en) Method of chain combination
CS253388A2 (en) Method of 10-dihydro-10-dexy-11-azarythronolides prepararation
GB8716946D0 (en) Compile method
EP0246898A3 (en) Method of curve approximation
GB8727818D0 (en) Chain
PL264722A1 (en) Method of obtaining alkylsulfony-alkyl-chlorobenzenes
EP0270497A3 (en) Dough-rolling method
PL269047A1 (en) Method of obtaining novel 1-aryloxy-3-amino-2-propanols
GB8703500D0 (en) Chain
CS556987A2 (en) Method of n-paraffine removal
PL267876A1 (en) Method of obtaining novel aryloxyaminoalkanes
GB2192376B (en) Method of packaging
BG42954A1 (en) Chain
BG41073A1 (en) Non- regulable connection of chain
GB8605160D0 (en) Method
GB8708643D0 (en) Masking method
SU1428374A1 (ru) Cпocoб иpидoпpoteзиpobahия
CS274683B2 (en) Method of dialkyldichlorosuccinates
PL262333A1 (en) Method of obtaining -damascone
PL266886A1 (en) Method of obtaining novel tetrahydrobenzothiazoquinolines
PL263463A2 (en) Method of obtaining /n-alkyloaminoacetylo/-ureas
PL257770A1 (en) Method of obtaining spirocompounds
PL262456A1 (en) Method of obtaining phenycyclosiloxanes
PL261310A2 (en) Method of obtaining waffers
PL257791A1 (en) Method of obtaining 2-methyl-1-pyroline